OncoMed Pharmaceuticals Inc: capex
| Value | {"amount": 585000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | OncoMed Pharmaceuticals Inc |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:24:59.902707+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6140f8fa-0170-4f97-9a4a-7ef05093afc3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-18-005014 · Open the official SEC filing →Retrieved: 2026-08-19T12:24:59.902707+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001302573/capex/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6140f8fa-0170-4f97-9a4a-7ef05093afc3
History
- no predecessors — first report